GeneFerm Biotechnology Co EBITDA TCAC 3A

Que fait GeneFerm Biotechnology Co ? GeneFerm Biotechnology Co Ltd is a company based in Tainan, Taiwan, operating within the Consumer Staples sector and the Consumer products industry. It went public on July 26, 2016, with the ticker symbol 1796.TWO and ISIN TW0001796001. The company focuses on the manufacture and sale of health food and dietary supplements. Its product portfolio includes fermented products, medicinal mushrooms, lactic acid bacteria products, and fruit and vegetable fermented concentrates. GeneFerm also offers related manufacturing services, as well as health food design, research, and development services. The company's headquarters are located in Tainan, Taiwan, and it maintains a website at https://www.geneferm.com/. As a publicly traded entity, GeneFerm Biotechnology Co Ltd is listed on the Taiwan Stock Exchange, providing investors with access to its financial performance and corporate activities. The company's operations are centered around the development and production of health-focused food and supplement products, emphasizing natural and fermented ingredients. Its services extend beyond product manufacturing to include design, R&D, and manufacturing support for health food solutions. The firm has been active in the market since its IPO in 2016, contributing to the consumer staples sector with its specialized health food offerings. GeneFerm Biotechnology Co est l'une des entreprises les plus populaires sur Eulerpool.